MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy

NARecruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

April 26, 2023

Primary Completion Date

May 1, 2026

Study Completion Date

May 1, 2026

Conditions
Prostate CancerProstate AdenocarcinomaProstate Neoplasm
Interventions
OTHER

Risk Map Decision Support System (DSS).

The Risk Map DSS tool is an image analysis software that automatically interprets images of the prostate that were captured using an MR (magnetic resonance) scanner (an imaging technique that uses scanners to take pictures of the body). This tool can potentially identify additional areas of cancer in your prostate that may have otherwise been missed.

RADIATION

Magnetic Resonance Imaging (MRI)

A medical imaging test that uses a large machine/scanner to take images of the body and internal organs and structures.

PROCEDURE

Magnetic Resonance Imaging (MRI) Guided Biopsy

A removal of tumor tissue from the body based on images of the prostate provided by a previous magnetic resonance imaging (MRI) test. Up to 2 biopsies on trial.

Trial Locations (1)

60637

RECRUITING

University of Chicago Medicine Comprehensive Cancer Center, Chicago

All Listed Sponsors
lead

University of Chicago

OTHER